Macrophages heterogeneity in atherosclerosis - implications for therapy

Area of Science:

• Immunology
• Cardiovascular Science

Background:

• Atherosclerosis is a chronic inflammatory disease of the artery wall.
• Monocyte/macrophages are key immune cells in atherosclerosis pathogenesis.
• Cholesterol-loaded macrophages drive plaque development, rupture, and thrombosis.

Purpose of the Study:

• To review current understanding of macrophage subsets and their precursors in atherosclerosis.
• To explore the implications of macrophage heterogeneity for disease.
• To identify novel diagnostic and therapeutic targets based on macrophage subsets.

Main Methods:

• Literature review of macrophage subsets and their role in atherosclerosis.
• Analysis of macrophage functions in different stages of plaque development.
• Exploration of therapeutic strategies targeting macrophage heterogeneity.

Main Results:

• Macrophages exhibit heterogeneity with diverse roles in atherosclerosis.
• Activated macrophages can promote or resolve inflammation and plaque instability.
• Specific macrophage subsets influence lipid metabolism, inflammation, and plaque stability.

Conclusions:

• Macrophage heterogeneity is crucial in atherosclerosis development and progression.
• Targeting specific macrophage subsets presents a promising therapeutic strategy.
• Further research into macrophage subsets can lead to improved diagnostics and treatments for atherosclerosis.